TG Therapeutics

TGTX • NASDAQ • Stock Fundamentals

TG Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael S. Weiss, with a market cap of $7.4B.

Market Cap$7.4B

Employees264.0

CEOMichael S. Weiss

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 3, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about TG Therapeutics

TG Therapeutics (TGTX) has a market capitalization of $7.4B and trades on NASDAQ.

TG Therapeutics has approximately 264 employees.